Askel Healthcare to Present First Clinical Trial Results of Its COPLA® Knee Cartilage Implant at the 9th Joint Preservation Congress in Warsaw, Poland on June 14-15, 2024

Askel Healthcare Celebrates Milestone Achievement: Patent Granted for Innovative Knee Cartilage Repair Technology

Askel Healthcare Ltd Announces Strategic Board Appointments and New Chairman

Access to Askel Healthcare’s investor event recording

Askel Healthcare has appointed globally renowned orthopedic surgeons and sports medicine specialists to its new Clinical Advisory Board to drive change in the treatment of knee cartilage repair

Invitation to Askel Healthcare investor event on 24 May at 16:00 EEST

Askel Healthcare to raise 5 million euros for clinical research of its COPLA® -implant to treat knee pain caused by cartilage damage

Askel Healthcare’s COPLA® implant on EVT, the national public television network of Estonia

First knee cartilage implant tested on Estonian can save people from knee pain

Askel Healthcare has reached an important milestone towards marketing authorization of the COPLA® implant in EU and the USA